The graph topology of CI-GC is designed to compute the structural correlation between neighboring vertices corresponding to each hop, thereby enriching the context of inter-vertex relationships. Then, ...

Alzheimer’s disease (AD) is a neurodegenerative disease with profound pathogenetic causes. Imaging genetic data analysis can provide comprehensive insights into its causes. To fully utilize the ...

According to Benzinga Pro, Vertex Pharmaceuticals's peer group average for short interest as a percentage of float is 6.62%, which means the company has less short interest than most of its peers. Did ...

Vertex Pharmaceuticals Incorporated VRTX stock has declined 8.9% in the past three months. The deterioration was due to soft first-quarter results, slower-than-expected uptake of its newer drugs ...

Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes. After a thorough review of the options trading surrounding Vertex Pharmaceuticals, we move ...

Vertex lays off 125 staffers, slims Rhode Island campus after ditching failed diabetes cell-device combo By Zoey Becker Jun 11, 2025 10:38am Vertex Pharmaceuticals biotech layoffs layoffs Rhode Island ...

Vertex will continue to work with reimbursement bodies across the European Union member states to ensure access for all eligible patients as quickly as possible.

On June 26, 2025, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stock closed at $443.40 per share, with a market capitalization of $113.864 billion.

The layoffs are coming because the company has stopped development of its "VX-264" program for Type 1 diabetes, Vertex Spokeswoman Nina Devlin wrote in an email. In all, 140 people are being laid ...